Frequency of the occurrence of atypical pathogens in hospitalized patients with CAP: a multi-country study

F. Blasi, M. Tamm, P. A. Wilcox, S. Fisher, P. Hogan (Milan, Italy; Basel, Switzerland; Cape Town, South Africa; New York, United States Of America)

Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Session: SARS and other lower respiratory tract infections
Session type: Poster Discussion
Number: 1582
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Blasi, M. Tamm, P. A. Wilcox, S. Fisher, P. Hogan (Milan, Italy; Basel, Switzerland; Cape Town, South Africa; New York, United States Of America). Frequency of the occurrence of atypical pathogens in hospitalized patients with CAP: a multi-country study. Eur Respir J 2004; 24: Suppl. 48, 1582

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Characterisation of children hospitalised with pneumonia in central Vietnam: A prospective study
Source: International Congress 2019 – Aetiology and management of childhood respiratory infections, primary ciliary dyskinesia and asthma
Year: 2019


Characterisation of children hospitalised with pneumonia in central Vietnam: a prospective study
Source: Eur Respir J, 54 (1) 1802256; 10.1183/13993003.02256-2018
Year: 2019



Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Comparative analysis of clinical and epidemiological characteristics of patients with CAP (community-acquired pneumonia) treated as inpatients and outpatients
Source: Eur Respir J 2006; 28: Suppl. 50, 3s
Year: 2006

The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006

Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010

The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017
Year: 2018



Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008

Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Impact of bacteremia in a cohort of predominantly elderly patients with pneumococcal pneumonia. Epidemiologic and case-control study
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018


Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Management of community-acquired pneumonia in primary care: an observational study
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019